Spineway (France) Performance
| ALSPW Stock | EUR 0.12 0.02 14.29% |
The entity has a beta of -0.57, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Spineway are expected to decrease at a much lower rate. During the bear market, Spineway is likely to outperform the market. At this point, Spineway has a negative expected return of -1.31%. Please make sure to validate Spineway's value at risk, as well as the relationship between the rate of daily change and relative strength index , to decide if Spineway performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Spineway has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
| Begin Period Cash Flow | 4.8 M | |
| Total Cashflows From Investing Activities | -578 K |
Spineway |
Spineway Relative Risk vs. Return Landscape
If you would invest 44.00 in Spineway on September 5, 2024 and sell it today you would lose (32.00) from holding Spineway or give up 72.73% of portfolio value over 90 days. Spineway is generating negative expected returns and assumes 12.4133% volatility on return distribution over the 90 days horizon. Simply put, majority of traded equity instruments are less risky than Spineway on the basis of their historical return distribution, and most equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Spineway Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Spineway's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Spineway, and traders can use it to determine the average amount a Spineway's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1057
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ALSPW |
Estimated Market Risk
| 12.41 actual daily | 96 96% of assets are less volatile |
Expected Return
| -1.31 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Spineway is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Spineway by adding Spineway to a well-diversified portfolio.
Spineway Fundamentals Growth
Spineway Stock prices reflect investors' perceptions of the future prospects and financial health of Spineway, and Spineway fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Spineway Stock performance.
| Return On Equity | -0.0836 | |||
| Return On Asset | -0.041 | |||
| Profit Margin | (0.42) % | |||
| Operating Margin | (0.43) % | |||
| Current Valuation | (9.62 M) | |||
| Shares Outstanding | 549.35 K | |||
| Price To Earning | (6.67) X | |||
| Price To Book | 0.06 X | |||
| Price To Sales | 0.06 X | |||
| Revenue | 4.27 M | |||
| EBITDA | (894.65 K) | |||
| Cash And Equivalents | 15.25 M | |||
| Cash Per Share | 35.73 X | |||
| Total Debt | 1.94 M | |||
| Debt To Equity | 0.20 % | |||
| Book Value Per Share | 50.36 X | |||
| Cash Flow From Operations | (1.52 M) | |||
| Earnings Per Share | 0.16 X | |||
| Total Asset | 25.25 M | |||
| Retained Earnings | (4 M) | |||
| Current Asset | 7 M | |||
| Current Liabilities | 5 M | |||
About Spineway Performance
Assessing Spineway's fundamental ratios provides investors with valuable insights into Spineway's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Spineway is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Spineway SA engages in the design, manufacture, and marketing of implants and surgical instruments for treating disorder of spinal column. Spineway SA was incorporated in 2005 and is headquartered in Ecully, France. SPINEWAY operates under Medical Instruments Supplies classification in France and is traded on Paris Stock Exchange. It employs 34 people.Things to note about Spineway performance evaluation
Checking the ongoing alerts about Spineway for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Spineway help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Spineway generated a negative expected return over the last 90 days | |
| Spineway has high historical volatility and very poor performance | |
| Spineway has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 4.27 M. Net Loss for the year was (1.51 M) with profit before overhead, payroll, taxes, and interest of 5.11 M. | |
| Spineway has accumulated about 15.25 M in cash with (1.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 35.73, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Spineway's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Spineway's stock is overvalued or undervalued compared to its peers.
- Examining Spineway's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Spineway's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Spineway's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Spineway's stock. These opinions can provide insight into Spineway's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Spineway Stock Analysis
When running Spineway's price analysis, check to measure Spineway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spineway is operating at the current time. Most of Spineway's value examination focuses on studying past and present price action to predict the probability of Spineway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spineway's price. Additionally, you may evaluate how the addition of Spineway to your portfolios can decrease your overall portfolio volatility.